InfuSystem Holdings DEFA14A Filing

TL;DR

InfuSystem Holdings filed proxy docs, no fee. Standard stuff.

AI Summary

InfuSystem Holdings, Inc. filed a Definitive Additional Materials (DEFA14A) on April 23, 2024. This filing relates to the company's proxy statement and indicates no fee was required for this filing. The company, previously known as HAPC, Inc. and Healthcare Acquisition Partners Corp., is incorporated in Delaware and operates in the surgical and medical instruments sector.

Why It Matters

This filing is a routine regulatory document that provides information to shareholders regarding proxy matters, which is essential for corporate governance and shareholder rights.

Risk Assessment

Risk Level: low — This filing is a standard DEFA14A, which is a routine regulatory disclosure and does not inherently present new risks.

Key Players & Entities

• InfuSystem Holdings, Inc. (company) — Registrant
• HAPC, Inc. (company) — Former Company Name
• Healthcare Acquisition Partners Corp. (company) — Former Company Name
• 0001628280-24-017301 (filing_id) — Accession Number
• 20240423 (date) — Filing Date

FAQ

Filing Documents

• def14acombinedcorrected.htm (DEFA14A) — 37KB
• a03ykfd_infusystemxholdi001.jpg (GRAPHIC) — 138KB
• a03ykfd_infusystemxholdi002.jpg (GRAPHIC) — 182KB
• i01a.jpg (GRAPHIC) — 2KB
• signature4a.jpg (GRAPHIC) — 8KB
• 0001628280-24-017301.txt ( ) — 493KB

From the Filing

14A def14Acombinedcorrected UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 InfuSystem Holdings, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box) No fee required. Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies (2) Aggregate number of securities to which transaction applies (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined) (4) Proposed maximum aggregate value of transaction (5) Total fee paid Fee paid previously with preliminary materials. Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount previously paid (2) Form, Schedule or Registration Statement No. (3) Filing party (4) Date Filed InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 Proxy Statement Supplement to Proxy Statement Filed April 10, 2024 2024 Annual Meeting of Stockholders April 23, 2024 To the Stockholders of InfuSystem Holdings, Inc. You most likely received a proxy card for InfuSystem Holdings, Inc.'s 2024 Annual Meeting of Stockholders (the "Annual Meeting") to be held virtually at 200 pm, Eastern Time, May 16, 2024. Due to a preparation error, you received an incorrect proxy card . Proposal 1 should have offered you the option to either vote FOR , AGAINST or to ABSTAIN your vote as to each individual director nominee identified in the Proxy Statement and on the proxy card. We have therefore enclosed a corrected proxy card that lists the correct voting options for Proposal 1. If you have already returned the original proxy card, you must return the enclosed corrected proxy card , using the enclosed reply envelope, to have your shares voted by proxy at the May 16, 2024 annual meeting. If you have already voted via the Internet or by telephone based on the incorrect proxy card, please return the enclosed revised proxy card or resubmit your vote via the Internet or by telephone following the instructions on the enclosed corrected proxy card . If you have not yet returned the original proxy card, please discard it and instead use the enclosed corrected proxy card , or vote via the Internet or by telephone following the instructions on the enclosed corrected proxy card . If your shares are held in the name of a bank, broker or other agent, please follow the instructions on the voting instruction card furnished by the bank, broker or other agent. We regret any inconvenience or confusion caused by the mailing of an erroneous proxy card, but chose to provide the corrected proxy card to ensure the integrity of the voting process. We appreciate your attention to this matter. Best Regards, Barry Steele Corporate Secretary InfuSystem Holdings, Inc. Proposals — The Board of Directors recommend a vote FOR all the nominees listed, FOR Proposals X – X and for every X YEARS on Proposal X. 02 - Richard DiIorio 05 - Beverly A. Huss For Against Abstain 03 - Kenneth D. Eichenbaum 06 - Carrie Lachance For Against Abstain 01 - Ralph Boyd 04 - Paul Gendron 07 - Scott Shuda For Against Abstain Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. 03YKFD + + 2. Approval, on an advisory basis, of the Company's executive compensation. 1. Election of Directors: For Against Abstain Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. Signature 1 — Please keep signature within the box. Signature 2 — Please keep signature within the box.Date (mm/dd/yyyy) — Please print date below. Authorized Signatures — This section must be completed for your vote to count. Please date and sign below.B q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q 2024 Annual Meeting – Corrected Proxy Card i t r r c ends a vote FOR all the nominees listed; FOR Pr posals 2 and 3.A 3. Ratification of the appointment of Deloitte & Touche LLP

View Full Filing

View this DEFA14A filing on SEC EDGAR